As shown in Table 2, ICC patients with an FGFR2 fusion/rearrangement presented with low levels of carcinoembryonic antigen (CEA, P = .026), gamma glutamyl transferase (γ-GGT, P = .003), and low CNCL/TNM staging. Here, FGFR2 is linked to intrahepatic cholangiocarcinoma.